IT1237509B - Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche - Google Patents

Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Info

Publication number
IT1237509B
IT1237509B IT02219989A IT2219989A IT1237509B IT 1237509 B IT1237509 B IT 1237509B IT 02219989 A IT02219989 A IT 02219989A IT 2219989 A IT2219989 A IT 2219989A IT 1237509 B IT1237509 B IT 1237509B
Authority
IT
Italy
Prior art keywords
cyclodestrine
folates
anemic
complexes
formulations
Prior art date
Application number
IT02219989A
Other languages
English (en)
Other versions
IT8922199A1 (it
IT8922199A0 (it
Inventor
Laura Puricelli
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Priority to IT02219989A priority Critical patent/IT1237509B/it
Publication of IT8922199A0 publication Critical patent/IT8922199A0/it
Priority to EP90120676A priority patent/EP0427078A1/en
Publication of IT8922199A1 publication Critical patent/IT8922199A1/it
Application granted granted Critical
Publication of IT1237509B publication Critical patent/IT1237509B/it

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT02219989A 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche IT1237509B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT02219989A IT1237509B (it) 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
EP90120676A EP0427078A1 (en) 1989-10-31 1990-10-29 Folinic acid-cyclodextrin inclusion compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02219989A IT1237509B (it) 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
IT8922199A0 IT8922199A0 (it) 1989-10-31
IT8922199A1 IT8922199A1 (it) 1991-05-01
IT1237509B true IT1237509B (it) 1993-06-08

Family

ID=11192944

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02219989A IT1237509B (it) 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Country Status (2)

Country Link
EP (1) EP0427078A1 (it)
IT (1) IT1237509B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684644A5 (de) * 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
US8372834B2 (en) 2007-03-02 2013-02-12 University Of Wollongong Compositions and methods for delivery of anti-cancer agents
CN102000345A (zh) * 2010-11-16 2011-04-06 广西大学 包合态的叶酸/β-环糊精组合物及其制备方法
CN107751576A (zh) * 2017-11-13 2018-03-06 厦门大学 一种复合维生素液及其制备方法
GR1009589B (el) * 2018-04-05 2019-09-11 Ιουλια Κλεωνος Τσετη Φαρμακευτικο σκευασμα για την αντιμετωπιση της αναιμιας, σε καταλληλο περιεκτη, που διατηρει στεγανα διαχωρισμενα μεταξυ τους τα δραστικα συστατικα: συμπλοκο του τρισθενους σιδηρου με ν-ακετυλο-l-ασπαρτικη καζεϊνη και πενταϋδρικο φυλλινικο ασβεστιο
GR1009597B (el) * 2018-04-16 2019-09-16 Ιουλια Κλεωνος Τσετη Φαρμακευτικο σκευασμα για την ενισχυση των επιπεδων σιδηρου στο αιμα, που περιεχει πολυμαλτοζικο σιδηρο (ιιι) και μια δραστικη ουσια επιλεγμενη απο πενταϋδρικο φυλλινικο ασβεστιο, βιταμινη c ή συνδυασμο των δυο, που ενισχυει την απορροφηση σιδηρου
CN112089848A (zh) * 2020-10-27 2020-12-18 浙江诺得药业有限公司 叶酸的环糊精包合物及其制备方法
CN112618500B (zh) * 2020-12-24 2022-12-09 广州汉光药业股份有限公司 叶酸制剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine

Also Published As

Publication number Publication date
EP0427078A1 (en) 1991-05-15
IT8922199A1 (it) 1991-05-01
IT8922199A0 (it) 1989-10-31

Similar Documents

Publication Publication Date Title
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
IT8547852A0 (it) Ciclosporine,processi per la loro preparazione,uso farmaceutico delle stesse e composizioni farmaceutiche che le contengono
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IL96019A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
IT9019829A0 (it) Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
IL93124A0 (en) Benzocycloalkenyldihydroxyalkanoic-acid derivatives,their preparation and pharmaceutical compositions
IT1237509B (it) Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
FI935066A7 (fi) Kardiovaskulaariseen järjestelmään aktiivisesti vaikuttavat 2-amino-1, 2,3,4-tetrahydronaftaleenijohdannaiset, menetelmät niiden valmistamise ksi ja niitä sisältävät farmaseuttiset koostumukset
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
IT1204571B (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
AU632313B2 (en) New platinum complexes, their preparation and pharmaceutical compositions which contain them
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
IL95760A0 (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing the same
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
ITMI911122A0 (it) Composizioni per la terapia topica delle ustioni
IT8720179A0 (it) 2-sulfinil-acetil-1,3-tiazolidine, loro preparazione e composizioni farmaceutiche.
IT1231944B (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
ZA905229B (en) Derivatives of taxol,pharmaceutical compositions thereof and methods for the preparation thereof
ITMI912938A0 (it) Complessi del platino(ii)anti-tumorali e procedimento per la loro preparazione
IT8619751A0 (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione.

Legal Events

Date Code Title Description
0001 Granted